SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-052561
Filing Date
2018-10-05
Accepted
2018-10-04 17:35:49
Documents
4
Period of Report
2018-09-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv504285_8k.htm 8-K 19744
2 EXHIBIT 10.1 tv504285_ex10-1.htm EX-10.1 64055
3 GRAPHIC image_001.jpg GRAPHIC 6244
4 GRAPHIC image_002.jpg GRAPHIC 6667
  Complete submission text file 0001144204-18-052561.txt   103399
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 181108587
SIC: 2834 Pharmaceutical Preparations